venetoclax with decitabine for high-risk aml and mds
Published 4 years ago • 672 plays • Length 2:05Download video MP4
Download video MP3
Similar videos
-
6:21
decitabine and venetoclax for aml
-
5:51
ten-day decitabine with venetoclax in acute myeloid leukaemia: updated outcomes across genomic s...
-
5:18
venetoclax plus decitabine or azacitidine in untreated acute myeloid...
-
6:23
venetoclax, clad/ldac and azacitdine in older aml patients
-
4:15
phase ib/ii trial of quizartinib, decitabine and venetoclax in flt3-itd-mutated aml
-
5:36
venetoclax and azacitidine in mds patients
-
2:50
pevonedistat, venetoclax and azacitidine for older aml patients
-
4:50
clinical trial results of new agent for myelodysplastic syndromes and acute myeloid leukemia
-
1:22
dr. daver on updated findings with magrolimab/azacitidine in mds
-
13:47
myelodysplastic syndrome (mds) - a precursor to acute myeloid leukemia (aml) ?! - hematology series
-
53:50
developing venetoclax in acute myeloid leukemia
-
45:46
acute myelogenous leukemia (aml)
-
3:20
thrombosis, myelofibrosis, and acute myeloid leukemia
-
3:03
venetoclax and 5-azacytidine for the treatment of mds and cmml
-
1:23
takeaim leukemia: emavusertib as monotherapy or with azacitidine or venetoclax in r/r aml or mds
-
10:15
acute myeloid leukemia | clinical presentation
-
2:17
outcomes of patients with monocytic aml treated with venetoclax & azacitidine
-
6:33
myelodysplastic syndromes - causes, symptoms, diagnosis, treatment, pathology
-
1:04
new approaches to treat myeloid neoplasms